KENDAL HOLBROOK: Open Payments
NPI 1992460448 · DANDRIDGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 55 payments from 16 companies in 2025. Trend: 2023 $1,117 · 2024 $1,090 · 2025 $1,023
Food & beverage: $978Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 8 | $166 |
| PFIZER INC. | 9 | $147 |
| Novo Nordisk Inc | 9 | $140 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $48 |
| Lilly USA, LLC | 1 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Corcept Therapeutics | 2 | $33 |
Products named: TRELEGY ELLIPTA, REXULTI, FARXIGA, ELIQUIS, NURTEC ODT, AIRSUPRA, Ozempic, Rybelsus.
Industry payments across TN — which companies pay providers there.
